glp-1 and breast cancer risk Have questions about GLP-1s affect on risk? 🩺 Join Dr. Elizabeth McDonald to learn what her recent study found, why observational research matters, what patients should know today. 📅 GLP-1s may reduce cancer risk

The Act aims to promote and protect public health and safety and to ensure the consumers of prescription and non-prescription medicines have adequate information and understanding necessary to allow them to use the medicines safely and effectively

Liraglutide and the preservation of pancreatic beta-cell function in early type 2 diabetes: the LIBRA trial

Whereas KIO 3 is characterized by the lowest redox potential among these three halogenate salts, potassium bromate (KBrO 3 ), a known potential renal carcinogen [166] belonging to the group 2B (possibly carcinogenic to humans) according to IARC classification [167], has a similar chemical structure to KIO 3 and for this reason, it cannot be excluded that iodate may also be potentially dangerous, at least in experimental conditions

Donoghue, M